Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1994 Apr 16;308(6935):1025–1027. doi: 10.1136/bmj.308.6935.1025

Statistical problems.

G Davey Smith 1, M Egger 1
PMCID: PMC2539918  PMID: 8167517

Full text

PDF
1025

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assmann G., Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study. Am J Cardiol. 1992 Sep 15;70(7):733–737. doi: 10.1016/0002-9149(92)90550-i. [DOI] [PubMed] [Google Scholar]
  2. Bass K. M., Newschaffer C. J., Klag M. J., Bush T. L. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med. 1993 Oct 11;153(19):2209–2216. [PubMed] [Google Scholar]
  3. Davis C. E., Rifkind B. M., Brenner H., Gordon D. J. A single cholesterol measurement underestimates the risk of coronary heart disease. An empirical example from the Lipid Research Clinics Mortality Follow-up Study. JAMA. 1990 Dec 19;264(23):3044–3046. [PubMed] [Google Scholar]
  4. Frick M. H., Elo O., Haapa K., Heinonen O. P., Heinsalmi P., Helo P., Huttunen J. K., Kaitaniemi P., Koskinen P., Manninen V. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987 Nov 12;317(20):1237–1245. doi: 10.1056/NEJM198711123172001. [DOI] [PubMed] [Google Scholar]
  5. Giles W. H., Anda R. F., Jones D. H., Serdula M. K., Merritt R. K., DeStefano F. Recent trends in the identification and treatment of high blood cholesterol by physicians. Progress and missed opportunities. JAMA. 1993 Mar 3;269(9):1133–1138. [PubMed] [Google Scholar]
  6. Hulley S. B., Walsh J. M., Newman T. B. Health policy on blood cholesterol. Time to change directions. Circulation. 1992 Sep;86(3):1026–1029. doi: 10.1161/01.cir.86.3.1026. [DOI] [PubMed] [Google Scholar]
  7. Hunninghake D. B., Stein E. A., Dujovne C. A., Harris W. S., Feldman E. B., Miller V. T., Tobert J. A., Laskarzewski P. M., Quiter E., Held J. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med. 1993 Apr 29;328(17):1213–1219. doi: 10.1056/NEJM199304293281701. [DOI] [PubMed] [Google Scholar]
  8. Law M. R., Thompson S. G., Wald N. J. Assessing possible hazards of reducing serum cholesterol. BMJ. 1994 Feb 5;308(6925):373–379. doi: 10.1136/bmj.308.6925.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Law M. R., Wald N. J., Thompson S. G. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994 Feb 5;308(6925):367–372. doi: 10.1136/bmj.308.6925.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Law M. R., Wald N. J., Wu T., Hackshaw A., Bailey A. Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. BMJ. 1994 Feb 5;308(6925):363–366. doi: 10.1136/bmj.308.6925.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Manolio T. A., Pearson T. A., Wenger N. K., Barrett-Connor E., Payne G. H., Harlan W. R. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol. 1992 Jan-Mar;2(1-2):161–176. doi: 10.1016/1047-2797(92)90051-q. [DOI] [PubMed] [Google Scholar]
  12. Phillips A. N., Smith G. D. The design of prospective epidemiological studies: more subjects or better measurements? J Clin Epidemiol. 1993 Oct;46(10):1203–1211. doi: 10.1016/0895-4356(93)90120-p. [DOI] [PubMed] [Google Scholar]
  13. Ramsay L. E., Yeo W. W., Jackson P. R. Dietary reduction of serum cholesterol concentration: time to think again. BMJ. 1991 Oct 19;303(6808):953–957. doi: 10.1136/bmj.303.6808.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Shestov D. B., Deev A. D., Klimov A. N., Davis C. E., Tyroler H. A. Increased risk of coronary heart disease death in men with low total and low-density lipoprotein cholesterol in the Russian Lipid Research Clinics Prevalence Follow-up Study. Circulation. 1993 Sep;88(3):846–853. doi: 10.1161/01.cir.88.3.846. [DOI] [PubMed] [Google Scholar]
  15. Smith G. D. Blood cholesterol and non-coronary mortality. Coron Artery Dis. 1993 Oct;4(10):860–866. doi: 10.1097/00019501-199310000-00004. [DOI] [PubMed] [Google Scholar]
  16. Smith G. D., Egger M. Who benefits from medical interventions? BMJ. 1994 Jan 8;308(6921):72–74. doi: 10.1136/bmj.308.6921.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Smith G. D., Shipley M. J., Marmot M. G., Rose G. Plasma cholesterol concentration and mortality. The Whitehall Study. JAMA. 1992 Jan 1;267(1):70–76. [PubMed] [Google Scholar]
  18. Smith G. D., Song F., Sheldon T. A. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ. 1993 May 22;306(6889):1367–1373. doi: 10.1136/bmj.306.6889.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Stamler J., Stamler R., Brown W. V., Gotto A. M., Greenland P., Grundy S., Hegsted D. M., Luepker R. V., Neaton J. D., Steinberg D. Serum cholesterol. Doing the right thing. Circulation. 1993 Oct;88(4 Pt 1):1954–1960. doi: 10.1161/01.cir.88.4.1954. [DOI] [PubMed] [Google Scholar]
  20. Witztum J. L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991 Dec;88(6):1785–1792. doi: 10.1172/JCI115499. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES